Mycophenolate-mofetil in the treatment of refractory multiple sclerosis
โ Scribed by Norbert Ahrens; Abdulgabar Salama; Judith Haas
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 109 KB
- Volume
- 248
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Paraneoplastic pemphigus (PNP) is a rare autoimmune blistering disease with circulating antibodies that bind the cell surface of the epidermis and other non-stratifying epithelia, and immunoprecipitate a complex of four or five proteins (250 kDa, 230 kDa, 210 kDa, 190 kDa and occasional
## Objective: To examine the safety of mycophenolate mofetil (mmf) for remission maintenance in patients with wegener's granulomatosis (wg) who had been treated with daily cyclophosphamide (cyc) and glucocorticoids to induce remission. ## Methods: Fourteen patients were treated for active wg usin
Eight patients whose severe psoriasis was treated with long-term cyclosporin (range 2-11 years; mean 7.6 years) were changed to mycophenolate mofetil (MMF), because of nephrotoxicity in seven and hypertension and lack of efficacy in one. In five patients psoriasis control significantly deteriorated